Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Accumulated Expenses (2016 - 2018)

Sol-Gel Technologies (SLGL) posted quarterly Accumulated Expenses of $1.0 million for Q4 2018, up 13.3% year-over-year from $910000.0 in Q4 2017, and down 29.77% quarter-over-quarter from $1.5 million in Q3 2018.

Analysis

Sol-Gel Technologies (SLGL) Accumulated Expenses (2016 - 2018) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Accumulated Expenses for 3 consecutive years, with $1.0 million the latest figure, recorded in Q4 2018.

  • In Q4 2018, Accumulated Expenses rose 13.3% year-over-year to $1.0 million; the TTM figure through Dec 2018 stood at $1.0 million (up 13.3% YoY), while the FY2018 annual figure was $1.0 million, up 13.3% from the prior year.
  • Accumulated Expenses retreated to $1.0 million in Q4 2018 per SLGL's latest filing, from $1.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.6 million in Q4 2016 and bottomed at $910000.0 in Q4 2017.
  • Historically, Accumulated Expenses has averaged $1.7 million across 3 years, with a median of $1.5 million in 2018.
  • Annual changes were most pronounced in 2017 — Accumulated Expenses tumbled 74.88% — and 2018, when it gained 13.3%.
  • Sol-Gel Technologies' Accumulated Expenses stood at $3.6 million in 2016, then slumped by 74.88% to $910000.0 in 2017, then increased by 13.3% to $1.0 million in 2018.
  • Business Quant data shows SLGL's Accumulated Expenses at $1.0 million in Q4 2018, $1.5 million in Q3 2018, and $1.5 million in Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.03 Mn
Sep 30, 2018 1.47 Mn
Mar 31, 2018 1.53 Mn
Dec 31, 2017 910,000.00
Dec 31, 2016 3.62 Mn